ACM
Ashford Capital Management Portfolio holdings
AUM
$851M
1-Year Return
36.83%
This Quarter Return
+11.91%
1 Year Return
+36.83%
3 Year Return
+110.61%
5 Year Return
+172.96%
10 Year Return
+1,058.17%
AUM
$841M
AUM Growth
+$69.2M
(+9%)
Cap. Flow
-$11.9M
Cap. Flow
% of AUM
-1.42%
Top 10 Holdings %
Top 10 Hldgs %
37.42%
Holding
104
New
7
Increased
29
Reduced
51
Closed
7
Top Buys
| 1 |
Health Catalyst
HCAT
|
+$12.5M |
| 2 |
SMAR
Smartsheet Inc.
SMAR
|
+$11.6M |
| 3 |
PFPT
Proofpoint, Inc.
PFPT
|
+$8.89M |
| 4 |
Great Lakes Dredge & Dock
GLDD
|
+$8.27M |
| 5 |
Viasat
VSAT
|
+$7.69M |
Top Sells
| 1 |
LVGO
Livongo Health, Inc. Common Stock
LVGO
|
+$37.8M |
| 2 |
Trade Desk
TTD
|
+$9.95M |
| 3 |
Five Below
FIVE
|
+$8.13M |
| 4 |
Twilio
TWLO
|
+$6.09M |
| 5 |
Fiverr
FVRR
|
+$6.07M |
Sector Composition
| 1 | Technology | 27.29% |
| 2 | Industrials | 16.31% |
| 3 | Communication Services | 15.04% |
| 4 | Healthcare | 11.48% |
| 5 | Financials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Brown & Brown
BRO
$31.5B
| $634K | 0.08% |
14,000
| – | – |
|
77
Morningstar
MORN
$10.9B
| $613K | 0.07% |
3,819
+526
| +16% | +$84.4K |
|
78
Woodward
WWD
$14.4B
| $601K | 0.07% |
7,501
+853
| +13% | +$68.3K |
|
79
Bio-Techne
TECH
$8.42B
| $528K | 0.06% |
8,524
+5,224
| +158% | +$324K |
|
80
Ligand Pharmaceuticals
LGND
$3.23B
| $499K | 0.06% |
8,400
-641
| -7% | -$38.1K |
|
81
Mercado Libre
MELI
$119B
| $433K | 0.05% |
400
-50
| -11% | -$54.1K |
|
82
SPDR S&P 500 ETF Trust
SPY
$661B
| $422K | 0.05% |
+1,259
| New | +$422K |
|
83
Blackstone
BX
$135B
| $407K | 0.05% |
7,800
-1,000
| -11% | -$52.2K |
|
84
Merck
MRK
$210B
| $373K | 0.04% |
4,716
-210
| -4% | -$16.6K |
|
85
Johnson & Johnson
JNJ
$429B
| $328K | 0.04% |
2,200
| – | – |
|
|
MXIM
86
DELISTED
Maxim Integrated Products
MXIM
| $270K | 0.03% |
4,000
| – | – |
|
87
Corning
GLW
$61.8B
| $264K | 0.03% |
8,136
| – | – |
|
88
Datadog
DDOG
$47.6B
| $255K | 0.03% |
2,500
-4,454
| -64% | -$454K |
|
89
AT&T
T
$207B
| $253K | 0.03% |
11,770
| – | – |
|
90
T Rowe Price
TROW
$23.8B
| $251K | 0.03% |
1,959
| – | – |
|
91
Bristol-Myers Squibb
BMY
$95.1B
| $238K | 0.03% |
3,950
-1,000
| -20% | -$60.3K |
|
92
Verizon
VZ
$183B
| $233K | 0.03% |
3,913
-2,000
| -34% | -$119K |
|
93
Biogen
BIIB
$20.7B
| $227K | 0.03% |
800
-200
| -20% | -$56.8K |
|
94
UDR
UDR
$12.8B
| $226K | 0.03% |
6,916
-1,750
| -20% | -$57.2K |
|
95
Illumina
ILMN
$15.1B
| $223K | 0.03% |
740
-72
| -9% | -$21.7K |
|
96
Procter & Gamble
PG
$372B
| $203K | 0.02% |
+1,462
| New | +$203K |
|
|
RA
97
Brookfield Real Assets Income Fund
RA
$749M
| $175K | 0.02% |
10,622
-176,892
| -94% | -$2.91M |
|
98
Chevron
CVX
$310B
| – | – |
-2,670
| Closed | -$238K |
|
99
Intel
INTC
$114B
| – | – |
-4,400
| Closed | -$263K |
|
100
Eli Lilly
LLY
$662B
| – | – |
-1,366
| Closed | -$224K |
|